I'm focusing on the active consumers and subscription plans as it gives us a view of the future.
After watching the moves in Trillium Therapeutics, a Real Money reader wants to play CRDF. Here's the what the charts say.
Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.
I think it's all about peak Delta or lack thereof.
Let's see if his intuition is right on ISRG.
We don't have a lot of price history, but what we do see is bullish for DOCS.
The technical signs of the provider of senior housing are mixed at present.
These picks are attractive for value-oriented dividend investors looking for strong current income potential.
The shares are only trading at 17 times forward earnings, and might not be fully valued just yet.
The charts of the vaccine maker indicate it's a good time to take some profits or raise stops, or both.